A
AbbVie
Discovering and Delivering Medicines
North Chicago, IL
50,000+
About AbbVie
Industry:
Pharmaceuticals
Founded:
2013
Founders:
Abbott spin-off
Status:
Public (NYSE: ABBV)
Funding & Growth
Total Raised:
N/A
Valuation:
$310B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Strong revenue
- • Diverse portfolio
- • Good compensation
- • Research investment
- • Stable company
✗ Cons
- • Chicago area location
- • Humira loss of exclusivity
- • Large company processes
- • Some bureaucracy